You are here

Article info

Article menu

Download PDFPDF

XML
Basic tumor immunology
Original research
Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression

Authors

  • Liang Wang State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Yi-Yang Hu State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Jun-Long Zhao State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Fei Huang State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Shi-Qian Liang State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Lei Dong State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Yan Chen Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Heng-Chao Yu Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Jian Bai State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Jia-Meng Yang State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Jie-Yi Fan State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Lei Feng State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • San-Zhong Li State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Hua Han State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  • Hong-Yan Qin State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, Shaanxi, China PubMed articlesGoogle scholar articles
  1. Correspondence to Hong-Yan Qin; hyqin{at}fmmu.edu.cn
View Full Text

Citation

Wang L, Hu Y, Zhao J, et al
Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression
Journal for ImmunoTherapy of Cancer 2020;8:e000517. doi: 10.1136/jitc-2019-000517

Publication history

  • Accepted August 12, 2020
  • First published September 18, 2020.
Online issue publication 
September 18, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.